Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

Dr. Axel Grothey talks with Targeted Oncology how #HER2 has become an actionable target for #GIcancers and potential HER2-targeted treatments in the field, as well as other interesting studies from the role trastuzumab plays in the GI cancer clinical space.

Click to read a transcript of this full interview!

X